16.9
Streptococcal pharyngitis, commonly known as strep throat, is caused by the Gram-positive bacterium Streptococcus pyogenes.
The pathogen spreads through respiratory droplets. After entering the host, it attaches to epithelial cells of the throat using surface proteins such as lipoteichoic acid and M protein.
The bacteria also possess a capsule made of hyaluronic acid. This capsule mimics the host tissue and evades immune detection.
Once established, the pathogen releases several enzymes and toxins.
Streptolysins lyse host epithelial cells and infiltrating leukocytes.
Hyaluronidase degrades connective tissue, facilitating bacterial invasion. The host confines the infection by forming fibrin clots around the bacteria.
Streptokinase converts plasminogen into plasmin, which degrades fibrin clots and enables further bacterial spread.
These actions cause throat inflammation with redness, swelling, and white patches.
Symptoms typically begin two to five days after exposure and include sore throat, fever, headache, and tender neck lymph nodes.
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.
Upon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic M protein. The M protein promotes robust attachment to host tissue and inhibits complement activation and opsonization, which impedes immune detection and phagocytosis. At the same time, the bacterium’s hyaluronic acid capsule mimics host connective tissue, further evading immune recognition.
Once colonization is established, S. pyogenes secretes a suite of extracellular enzymes and toxins that degrade host tissue and promote bacterial spread. Streptolysins O and S form pores in the membranes of erythrocytes and leukocytes, leading to cell lysis and contributing to local tissue damage. Hyaluronidase cleaves hyaluronic acid within the extracellular matrix, increasing tissue permeability and aiding bacterial penetration. Streptokinase converts plasminogen to plasmin, dissolving fibrin clots and enabling the bacteria to escape from localized confinements imposed by the host’s hemostatic defenses. In some cases, superantigens such as streptococcal pyrogenic exotoxins provoke systemic responses, contributing to complications like scarlet fever.
The combined action of these virulence factors triggers a vigorous inflammatory response in the pharyngeal mucosa. Clinically, this presents as the acute onset of sore throat, fever, headache, and tender cervical lymphadenopathy. Mucosal inflammation typically develops two to five days after exposure to the pathogen. Physical findings often include erythema, edema, and purulent exudates or white patches on the tonsillar pillars and pharyngeal walls.
Together, the mechanisms of adherence, immune evasion, enzymatic tissue degradation, and clot dissolution result in the characteristic clinical syndrome of streptococcal pharyngitis. Understanding this pathogenesis is key to guiding timely diagnosis and treatment, which not only relieves symptoms but also helps prevent complications such as rheumatic fever and post-streptococcal glomerulonephritis.
Streptococcal pharyngitis, commonly known as strep throat, is caused by the Gram-positive bacterium Streptococcus pyogenes.
The pathogen spreads through respiratory droplets. After entering the host, it attaches to epithelial cells of the throat using surface proteins such as lipoteichoic acid and M protein.
The bacteria also possess a capsule made of hyaluronic acid. This capsule mimics the host tissue and evades immune detection.
Once established, the pathogen releases several enzymes and toxins.
Streptolysins lyse host epithelial cells and infiltrating leukocytes.
Hyaluronidase degrades connective tissue, facilitating bacterial invasion. The host confines the infection by forming fibrin clots around the bacteria.
Streptokinase converts plasminogen into plasmin, which degrades fibrin clots and enables further bacterial spread.
These actions cause throat inflammation with redness, swelling, and white patches.
Symptoms typically begin two to five days after exposure and include sore throat, fever, headache, and tender neck lymph nodes.
From Chapter 16:
Now Playing
Bacterial Diseases
125 Views
Bacterial Diseases
391 Views
Bacterial Diseases
176 Views
Bacterial Diseases
53 Views
Bacterial Diseases
42 Views
Bacterial Diseases
47 Views
Bacterial Diseases
49 Views
Bacterial Diseases
60 Views
Bacterial Diseases
26 Views
Bacterial Diseases
306 Views
Bacterial Diseases
159 Views
Bacterial Diseases
46 Views
Bacterial Diseases
108 Views
Bacterial Diseases
186 Views
Bacterial Diseases
263 Views